Global Point-of-Care Blood Diagnostics Market is poised to witness a CAGR of 6% by 2026 – Rising Occurrences of Cardiovascular & Infectious Diseases
Medi-Tech Insights
Healthcare Business Research & Insights for Private Equity & Corporates
Point-of-care (POC) testing entails performing a diagnostic test outside of a laboratory, or near a patient and at the site where care or treatment is provided. POC testing provides an accurate and timely results, assisting in the diagnosis and treatment of acute infections and chronic disorders. Major tests/products within POC blood diagnostics market include equipment/assays/reagents for blood gas, blood glucose, cardiac markers, infectious diseases, coagulation, hematology, and immunoassays.
New Product Launches in POC Blood Diagnostics to drive the Global Market
Consistent advancements in disease diagnostics segment have enabled to develop an efficient POC devices and technologies such as real-time patient data management remotely, rapid result delivery, requirement of low volume of blood, and multiplexing capability, among others. Such advancements tend to provide a competitive edge to manufacturers and therefore, all leading market players are focusing on investing in research activities for new product development and expanding their geographic reach to strengthen their business positions in the point-of-care blood diagnostics market. Some of the technological advancements are listed below:
Trends in Point-of-Care Blood Diagnostics to trigger the Growth of the POC Blood Diagnostics Market
Connected Health Technology: Healthcare practitioners (HCPs) understand the importance of integrating connected health and artificial intelligence (AI) in POC blood diagnostics to deliver real-time results. More POC testing solutions driven by digital technologies to reduce the workload are expected by HCPs. For instance, AI can pick-up blind spots that are sometimes not visible to human eye, further assisting HCPs in quickly sorting patient data and providing efficient patient care.
领英推荐
Multiplex Testing: Leading market players are continuously focus on improving their existing portfolio in terms of high quality such accuracy (specificity/sensitivity) and faster turn-around times as well as develop innovative technologies. Owing to the unmet needs within infectious disease diagnostics segment, many new companies are coming in and focusing on launching POC molecular multiplexing systems which is expected to trigger the growth of this segment. Major application areas for this disrupting technology are meningitis and septicaemia. Multiplex testing offers numerous advantages such as time optimization by detection of multiple pathogens, more convenient and comfortable sample collection for patients, and cost-effectiveness as compared to other tests, among others.
Competitive Landscape Analysis: POC Blood Diagnostics Market
The global POC blood diagnostics market is marked by the presence of leading market players such as Radiometer (Denmark); WERFENLIFE VENTURES SL (Spain); 罗氏公司 (Switzerland); 雅培 (US); Nova Biomedical (US); and others.*
Get Detailed Insights on POC Blood Diagnostics Market with TOC & Sample Report @ https://meditechinsights.com/point-of-care-poc-blood-diagnostics-market/
#poc #pointofcare #blooddiagnostics #diagnostics #cardiovasculardisease #cardiovascular #cardiovascularhealth #infectiousdiseases #diseases #bloodpressure #bloodcancer #bloodtest #diagnostictest #treatments #chronicdiseases #bloodglucose #cardiacmarkers #coagulation #hematology #immunoassay #assays #diseaseprevention #patientcare #patientsafety #patientdata #connectedhealth #artificialintelligence #aiinhealthcare #digitaltechnologies #healthcaretechnology #healthcare #medicalcare